Envoy Medical, Inc. Class A COCH 深 滬
等待開盤 07-22 09:30:00 美东时间
0.6805
+0.010
+1.42%
華盛通- 最 高0.7899
- 今 開0.694
- 成交量 80.55万股
- 最 低 0.68
- 昨 收 0.671
- 總市值 5.23万
- 52周最高 1.89
- 市盈率 靜 --
- 換手率 1047.70%
- 52周最低 0.3625
- 委 比 92.37%
- 總股本 7.69万
- 歷史最高 11.72
- 量 比 1.02
- 振 幅 16.38%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅284.62%！Annexon获Needham上调目标价至25美元；多家大行上调美国银行目标价
今日重点评级关注：Needham：维持Annexon"买入"评级，目标价从11美元升至25美元；Benchmark：维持Prenetics Global"买入"评级，目标价从30美元升至40美元
07-16 18:55
HC Wainwright & Co. Reiterates Buy on Envoy Medical, Maintains $2.5 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Envoy Medical (NASDAQ:COCH) with a Buy and maintains $2.5 price target.
07-15 19:45
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results
Envoy Medical Inc. (NASDAQ:COCH) on Tuesday reported 12-month results from the first 10 participants in Stage 1 of its pivotal clinical trial evaluating the investigational fully implanted Acclaim cochlear implant, with hearing performance continuing to improve over previously reported six-month dat...
07-14 21:01
Envoy Medical Terminates At-The-Market Equity Facility To Offer, Sell $15M Common Shares
Envoy Medical®, Inc. (NASDAQ:COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has formally terminated its at-the-market equity facility (the "ATM Facility"). The ATM Facility, under which the Company was previously authorized to ...
06-25 20:40
Envoy Medical Secures Multiple Australia And Europe Patents For Implantable Hearing System Innovations And Battery Recharge Safety Technology
ustralian and European Patent Offices Grant the Company Four Patents Relating to Key Innovations in Implantable System Design, Signal Analysis, and Battery Recharge SafetyWhite Bear Lake, Minnesota--(Newsfile Corp. - May
05-20 20:39
Envoy Medical Q1 EPS $(0.08) Beats $(0.14) Estimate, Sales $39.000K Miss $60.000K Estimate
Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.14) by 42.86 percent. This is a 72.41 percent increase over losses of $(0.29) per share from the
05-11 20:13
Envoy Medical Achieves Full Enrollment Of U.S. Pivotal Clinical Study To Evaluate Fully Implanted Cochlear Implant Seeking FDA Nod
Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today reported first quarter 2026 results and landmark achievements that
05-11 20:10
Envoy Medical Announces First Podium Presentations Of Clinical Data From First Stage Of Pivotal Clinical Study Of Investigational Acclaim Cochlear Implant, Fully Implanted Cochlear Implant System
Positive Initial 6-Month Data from First 10 Patients and Improvements in Speech Understanding and Quality of Life Scores Presented; Additional Presentations Scheduled in Early MayDetails to be Discussed During Fireside
04-28 20:38
美股大行评级 | 存储分歧大！花旗大砍17%将美光目标价从510降至425美元；Bernstein上调希捷科技目标价从500升至620美元
今日重点评级关注：Maxim Group：上调Theriva Biologics评级至"买入"，目标价1美元；HC Wainwright & Co.：维持Bicara Therapeutics"买入"评级，目标价从40美元升至42美元
04-01 16:34
HC Wainwright & Co. Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5
HC Wainwright & Co. analyst Yi Chen initiates coverage on Envoy Medical (NASDAQ:COCH) with a Buy rating and announces Price Target of $2.5.
03-31 19:04
